| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5184622
Max Phase: Preclinical
Molecular Formula: C17H16N2O5S
Molecular Weight: 360.39
Associated Items:
Representations
Canonical SMILES: CCOC(=O)NC(=O)c1ccsc1NC(=O)c1ccc(C(C)=O)cc1
Standard InChI: InChI=1S/C17H16N2O5S/c1-3-24-17(23)19-15(22)13-8-9-25-16(13)18-14(21)12-6-4-11(5-7-12)10(2)20/h4-9H,3H2,1-2H3,(H,18,21)(H,19,22,23)
Standard InChI Key: QFUXNHFQUDRADP-UHFFFAOYSA-N
Associated Targets(non-human)
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase 247 Activities
Mycobacterium tuberculosis 203094 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 360.39 | Molecular Weight (Monoisotopic): 360.0780 | AlogP: 3.09 | #Rotatable Bonds: 5 |
| Polar Surface Area: 101.57 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 6.08 | CX Basic pKa: | CX LogP: 3.03 | CX LogD: 1.79 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.80 | Np Likeness Score: -1.59 |
References
| 1. Liu J, Dai H, Wang B, Liu H, Tian Z, Zhang Y.. (2022) Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains., 227 [PMID:34700267] [10.1016/j.ejmech.2021.113932] |
Source
Source(1):